Good news
-
-
Gotta assume that’s ozempic, et al.
-
Seems believable given this:
How many people are on glp-1 inhibitors in the USA
As of 2024, around 12% of U.S. adults have used GLP-1 inhibitors like Ozempic or Wegovy, and approximately 6% are currently using them. These drugs are commonly prescribed for conditions like type 2 diabetes and obesity, with a growing number of people using them for weight loss alone. The use of GLP-1 drugs has surged in recent years due to their effectiveness in both blood sugar control and weight management.
-
This post is deleted!